FDA public health notification: unretrieved device fragments.

Press Release/Announcement

FDA public health notification: unretrieved device fragments.

March 12, 2019

Silver Spring MD, Center for Devices and Radiological Health, US Food and Drug Administration; January 15, 2008.

This notification alerts providers to the potential danger of unretrieved device fragments (UDFs), types of adverse events that may occur, and prevention strategies.

Free full text

Related Resources From the Same Author(s)

Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

June 2, 2021

FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change.

March 21, 2012

Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications.

March 4, 2015

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

February 3, 2021

Human Factors and Medical Devices.

September 27, 2017

Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.

July 31, 2012

FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

October 28, 2010

Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

July 1, 2009

Five Medication Safety Tips for Older Adults.

February 15, 2024

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

August 11, 2010

Related Resources

Medication guides: patient medication information. A proposed rule by the Food and Drug Administration.

June 28, 2023

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

February 17, 2021

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

Public Health Notification from FDA: Vail Products Enclosed Bed Systems.

March 28, 2012

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

August 11, 2010

Shelhigh, Inc. implantable medical devices.

May 2, 2007

See More About The Topic

Health Care Providers

Public Health

Retained Surgical Instruments and Sponges

FDA public health notification: unretrieved device fragments.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

FDA public health notification: unretrieved device fragments.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site

Submit Your Training

Continue as a Guest

Continue Logged In

Submit Your Training

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your Toolkit

Continue as a Guest

Continue Logged In

Submit Your Toolkit

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your WebM&M Case

Continue as a Guest

Continue Logged In

Submit Your WebM&M Case

Continue as a Guest

Already have a PSNet

Account?

New Users